RxDoctor Payments Data

Jonathan Huang, MD

Urology · Aurora, ILNPI 1104183417

Payments from drug & device makers

$988in general payments, 2019–2025

Across 22 payments — averaging $44.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$199
  • Intuitive Surgical$176
  • Olympus America Inc.$142
  • Progenics Pharmaceuticals, Inc.$106
  • Astellas Pharma US Inc$106
  • Integra Lifesciences Corporation$98
  • plus $161 from 5 others

What the payments were for

  • Food & beverage$988100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$988 in reported general payments places this provider in the 35th percentile of 550 urology providers in Illinois.

See all urology providers in Illinois

Medicare billing

Part B allowed, 2024
$207,250
Medicare patients
491
Services billed
2,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron26$23,482
Tamsulosin Hcl429$6,394
Finasteride348$4,474
Oxybutynin Chloride ErOxybutynin Chloride71$1,139
Cefdinir49$852
Doxazosin Mesylate19$233
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$210
Acetaminophen-CodeineAcetaminophen With Codeine53$205
Cephalexin52$193
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$60
Ciprofloxacin Hcl31$44
Levofloxacin13$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$106$23,48226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 550 urology providers in Illinois.

Other urology in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →